Specialist platform for tracking and growing brand visibility in AI answers
Profound tracks how AI answer engines such as ChatGPT, Perplexity, Gemini, Copilot, Claude and Google AI Overviews talk about your brand. It finds the prompts buyers use, reports share of voice and offers agent analytics and an AI Marketer, mainly for larger brands.
Latest: Raised a $96 million Series C at a $1 billion valuation, led by Lightspeed, in February 2026.
Best AI-visibility data here but it does one job, and pricing is opaque.
See all Profound alternatives, ranked →
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Ultragenyx's Fayuvi is the first-ever treatment for Sanfilippo syndrome type A — a one-time gene therapy priced at $3.95 million.
Profound just raised $180M at a $1.8B valuation to get brands named inside AI answers - the new SEO for a world where people ask a chatbot instead of clicking blue links.
